Human mesenchymal stem cells show promise in treating chronic lung infections

Hospital doctor who took {pound}41 000 in salary payments after contract ended loses appeal against erasure
4 May 2021
Child abuse hotline volume up during pandemic
4 May 2021

Human mesenchymal stem cells show promise in treating chronic lung infections

A study released today in Stem Cells Translational Medicine offers hope for those suffering from a chronic, difficult to treat condition called non-tuberculous mycobacteria (NTM) lung infection. The study describes how researchers at Case Western University developed a new model of NTM lung infection and then used it to show how effective human mesenchymal stem cells (hMSCs) are in treating this condition—and even which donor cells might be best for doing so.

Comments are closed.